# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001641172-25-007886
Filing Date
2025-04-30
Accepted
2025-04-30 17:15:06
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | formdefa14a.htm | DEFA14A | 14542
2 | GRAPHIC | formdefa14a_001.jpg | GRAPHIC | 1033267
3 | GRAPHIC | formdefa14a_002.jpg | GRAPHIC | 672932
| Complete submission text file | 0001641172-25-007886.txt |  | 2361576

Mailing Address 245 MAIN STREET SUITE 204 CHESTER NJ 07930
Business Address 1200 ROUTE 22 EAST BRIDGEWATER NJ 08807 302-743-2995
Tharimmune, Inc. (Filer) CIK: 0001861657 (see all company filings)

EIN.: 842642541 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-41210 | Film No.: 25897476
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)